GnRH analogues
Goserelin
Indexed · full review not ready
A U.S. Food and Drug Administration (FDA) product record exists for ZOLADEX. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
Peptide library · 54 records · 34 full reviews
Find a peptide.
Search by name. Full reviews explain the studies, results, and limits. Entries without a full review link to one source while review is pending.
See the VIP peptide review for an example of how a study result and product records are checked.
Filter the listOptional
How strong is the evidence?Established means an official review or strong studies in people support one defined use. Emerging means studies in people are still growing. Insufficient means reliable studies in people are missing or limited.
Review statusFull review means the evidence and its limits were checked. Indexed means a name and source are listed, but a full review is not ready yet.
Showing 41–54 of 54 peptides
GnRH antagonists
Cetrorelix
Indexed · full review not ready
A U.S. Food and Drug Administration (FDA) product record exists for CETROTIDE. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
GnRH antagonists
Ganirelix
Indexed · full review not ready
A U.S. Food and Drug Administration (FDA) product record exists for GANIRELIX. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
GnRH antagonists
Degarelix
Indexed · full review not ready
A U.S. Food and Drug Administration (FDA) product record exists for FIRMAGON. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
Amylin analogues
Pramlintide
Indexed · full review not ready
A U.S. Food and Drug Administration (FDA) product record exists for SYMLIN. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
Melanocortin receptor agonists
Setmelanotide
Indexed · full review not ready
A U.S. Food and Drug Administration (FDA) product record exists for IMCIVREE. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
Guanylate cyclase-C agonists
Linaclotide
Indexed · full review not ready
A U.S. Food and Drug Administration (FDA) product record exists for LINZESS. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
Guanylate cyclase-C agonists
Plecanatide
Indexed · full review not ready
A U.S. Food and Drug Administration (FDA) product record exists for TRULANCE. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
Ion-channel blocking peptides
Ziconotide
Indexed · full review not ready
A U.S. Food and Drug Administration (FDA) product record exists for PRIALT. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
Direct thrombin inhibitors
Bivalirudin
Indexed · full review not ready
A U.S. Food and Drug Administration (FDA) product record exists for ANGIOMAX. This site has not completed a full product or evidence review.
FDA record to check · Last checked 2026-08-02
Growth hormone secretagogues
GHRP-2
Indexed · full review not ready
The U.S. Food and Drug Administration (FDA) lists this substance in its compounding-risk materials. This site has not completed a full product or evidence review.
Unapproved or compounded · Last checked 2026-08-02
Hepatocyte growth factor modulators
Dihexa acetate
Indexed · full review not ready
The U.S. Food and Drug Administration (FDA) lists this substance in its compounding-risk materials. This site has not completed a full product or evidence review.
Unapproved or compounded · Last checked 2026-08-02
Melanocortin fragments
KPV
Indexed · full review not ready
The U.S. Food and Drug Administration (FDA) lists this substance in its compounding-risk materials. This site has not completed a full product or evidence review.
Unapproved or compounded · Last checked 2026-08-02
Growth factor analogues
PEG-MGF
Indexed · full review not ready
The U.S. Food and Drug Administration (FDA) lists this substance in its compounding-risk materials. This site has not completed a full product or evidence review.
Unapproved or compounded · Last checked 2026-08-02
Need an answer with sources you can share? Open the approval and research checker.
About these records
Why some entries have a full review
An entry can appear before its full review is ready. It links to a source, but it does not prove a benefit or safety claim. We publish a full review after checking the main sources, important limits, date, and each claim.